SynchroPET Company
We build the smallest Positron Emission Tomography (PET) Scanners in medical imaging and research. Our first device promises to disrupt the nuclear imaging market by providing a non invasive input function that makes all PET scanners more quantitative and better at diagnosis and treatment of diseases like cancer, alzheimers, and parkinson's. This new quantitative data opens up and accelerates new possibilities in personalized medical treatments and cures.
Total Funding:
$9.5M
Headquarters:
Stony Brook, New York, United States
Funding Status:
Early Stage Venture
Employee Number:
1-10
Last Funding Type:
Venture - Series Unknown
Technology:
P4 Medicine
Investor Type:
For Profit
Investors Number:
5
Founded Date:
2013-03-01
Industry:
Biotechnology, Health Care, Health Diagnostics, Medical Device